Addex Therapeutics Ltd. (ADXN)
6.87
+0.17
(+2.54%)
USD |
NASDAQ |
May 13, 16:00
Addex Therapeutics EPS Diluted (Quarterly) : -2.339 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.654 |
| Roche Holding AG | -- |
| Oculis Holding AG | -0.625 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.294M |
| Revenue (Quarterly) | 0.0198M |
| Total Expenses (Quarterly) | 2.314M |
| Enterprise Value | 6.439M |
| Gross Profit Margin (Quarterly) | 86.87% |
| Profit Margin (Quarterly) | -11.59K% |
| Earnings Yield | -132.4% |
| Normalized Earnings Yield | -132.39 |